The review included seven clinical trials and six observational studies, which involved more than 500,000 participants combined. Each trial and study also involved the use of three major commercial vaccines.
Researchers found efficacy for a two-dose regimen was 58 percent for adults and only 30 percent for children under age of 5. Additionally, a one-dose vaccine regimen seemed to provide similar protection as a two-dose regimen, within the six months following vaccination.
More articles on quality:
5 Maine hospitals with top nurse-patient communication scores
FDA tells NYC fertility physician to stop marketing 3-parent babies
Swedish Health CEO Dr. Guy Hudson overhauls concurrent surgery policy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
